Expert Opinion on Investigational Drugs

Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of Type 2 diabetes?
pp. 1091-1102(12)
Authors: Carolyn F Deacon; Bo Ahrén; Jens J Holst

Recent advances in the treatment of gestational diabetes
pp. 1103-1111(9)
Authors: Mukesh M Agarwal; John Punnose

Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity
pp. 1113-1122(10)
Authors: Timothy J Kowalski; Mark D McBriar

Update on male hormonal contraceptive agents
pp. 1123-1133(11)
Authors: Melanie Walton; Richard A Anderson

The farnesoid X receptor: a novel drug target?
pp. 1135-1148(14)
Authors: Thierry Claudel; Ekkehard Sturm; Folkert Kuipers; Bart Staels

Exploitation of silicon medicinal chemistry in drug discovery
pp. 1149-1157(9)
Authors: John S Mills; Graham A Showell

Lipopeptides, focusing on daptomycin, for the treatment of Gram-positive infections
pp. 1159-1169(11)
Author: Barry I Eisenstein

Combretastatin A4 phosphate: background and current clinical status
pp. 1171-1182(12)
Authors: Scott L Young; David J Chaplin

Anidulafungin: an echinocandin antifungal
pp. 1183-1197(15)
Author: Michael A Pfaller

Dawn of Aurora kinase inhibitors as anticancer drugs
pp. 1199-1201(3)
Author: Sheila A Doggrell

Targeting Metabolic Syndrome
pp. 1203-1206(4)
Author: Tung M Fong

The 17th International Conference on Antiviral Research
pp. 1207-1212(6)
Author: Robert W Buckheit

New Advances in Drug Discovery
pp. 1213-1215(3)
Author: Colin Macphee